









市場行情
/
股票
/
nasdaq-ogn
/

Organon & Co

OGN

7.185USD

+0.095+1.34%

收盤 12/26, 16:00（美東）報價延遲15分鐘

1.87B總市值

3.72本益比TTM



Organon & Co

7.185

+0.095+1.34%

概覽公司財務分析

概覽

公司

財務

分析

關於 Organon & Co 公司

Organon & Co. is a global healthcare company. The Company is engaged in developing and delivering health solutions through a portfolio of prescription therapies and medical devices within women's health, biosimilars and a franchise of established medicines across a range of therapeutic areas. It has a portfolio of approximately 70 medicines and products across a range of therapeutic areas. It has a portfolio of contraception and fertility brands, including Nexplanon, NuvaRing, and Follistim AQ. Its Biosimilars portfolio spans across immunology and oncology treatments. It also has a portfolio of established brands, including brands in cardiovascular, dermatology and non-opioid pain management. It sells these products through various channels, including drug wholesalers and retailers, hospitals, government agencies and managed health care providers, such as pharmacy benefit managers and other institutions.

Organon & Co簡介



公司代碼OGN

公司名稱Organon & Co

上市日期May 14, 2021

CEOMorrissey (Joseph T)

員工數量10000

證券類型Ordinary Share

年結日May 14

公司地址30 Hudson Street

城市JERSEY CITY

上市交易所NASDAQ OMX NASDAQ Basic NYSE

國家United States of America

郵編07302

電話15514306000

網址https://www.organon.com/

公司代碼OGN

上市日期May 14, 2021

CEOMorrissey (Joseph T)

Organon & Co公司高管



名稱

名稱/職務

職務

持股

持股變動

Mr. Matthew M. (Matt) Walsh

Chief Financial Officer, Executive Vice President

144.48K

+8.57%

Ms. Rachel A. Stahler

Executive Vice President, Chief Digital and Growth Officer

71.89K

+18.29%

Mr. Aaron Falcione

Chief Human Resources Officer, Executive Vice President

59.92K

+10.11%

Mr. Kirke Weaver

Executive Vice President, General Counsel, Corporate Secretary

52.85K

+17.96%

Mr. Vittorio Nisita

Executive Vice President, Head of Enterprise Services & Solutions

41.33K

+26.65%

Ms. Rochelle B. (Shelly) Lazarus

Independent Director

633.00

Ms. Shalini Sharp

Independent Director

2.00

Ms. Ramona A. Sequeira

Independent Director

Mr. Robert A. (Bob) Essner

Lead Independent Director

Ms. Grace M. Puma Whiteford

Independent Director

名稱

名稱/職務

職務

持股

持股變動

Mr. Matthew M. (Matt) Walsh

Chief Financial Officer, Executive Vice President

144.48K

+8.57%

Ms. Rachel A. Stahler

Executive Vice President, Chief Digital and Growth Officer

71.89K

+18.29%

Mr. Aaron Falcione

Chief Human Resources Officer, Executive Vice President

59.92K

+10.11%

Mr. Kirke Weaver

Executive Vice President, General Counsel, Corporate Secretary

52.85K

+17.96%

Mr. Vittorio Nisita

Executive Vice President, Head of Enterprise Services & Solutions

41.33K

+26.65%

Ms. Rochelle B. (Shelly) Lazarus

Independent Director

633.00

收入明細

單位: USD更新時間: 10月6日週一

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

業務USD

名稱

營收

佔比

Women’s Health

462.00M

28.98%

Cardiovascular

283.00M

17.75%

Non-Opioid Pain, Bone and Dermatology

250.00M

15.68%

Respiratory

220.00M

13.80%

Other

206.00M

12.92%

Biosimilars

173.00M

10.85%

地區USD

名稱

營收

佔比

Europe and Canada

419.00M

26.29%

United States

414.00M

25.97%

Latin America, Middle East, Russia and Africa

285.00M

17.88%

Asia Pacific and Japan

250.00M

15.68%

China

204.00M

12.80%

Other

22.00M

1.38%

業務

地區

業務USD

名稱

營收

佔比

Women’s Health

462.00M

28.98%

Cardiovascular

283.00M

17.75%

Non-Opioid Pain, Bone and Dermatology

250.00M

15.68%

Respiratory

220.00M

13.80%

Other

206.00M

12.92%

Biosimilars

173.00M

10.85%

股東統計

更新時間: 11月16日週日

持股股東

股東類型

持股股東

佔比

The Vanguard Group, Inc.

13.76%

BlackRock Institutional Trust Company, N.A.

10.68%

MFS Investment Management

3.63%

State Street Investment Management (US)

3.59%

LSV Asset Management

3.01%

其他

65.33%

持股股東

佔比

The Vanguard Group, Inc.

13.76%

BlackRock Institutional Trust Company, N.A.

10.68%

MFS Investment Management

3.63%

State Street Investment Management (US)

3.59%

LSV Asset Management

3.01%

其他

65.33%

股東類型

持股股東

佔比

Investment Advisor

47.62%

Investment Advisor/Hedge Fund

20.77%

Hedge Fund

4.75%

Pension Fund

2.56%

Research Firm

2.06%

Bank and Trust

0.92%

Sovereign Wealth Fund

0.86%

Individual Investor

0.36%

Venture Capital

0.04%

其他

20.06%

機構持股



更新時間: 10月1日週三

報告期間

機構數

持股數

持股佔比

持股變動

2025Q3

1485

219.88M

84.58%

-37.41M

2025Q2

1527

205.34M

78.98%

-50.49M

2025Q1

1611

213.21M

82.04%

-52.34M

2024Q4

1647

218.39M

84.67%

-40.43M

2024Q3

1625

211.80M

82.26%

-47.57M

2024Q2

1676

208.67M

81.14%

-51.47M

2024Q1

1700

205.29M

80.30%

-45.21M

2023Q4

1767

202.90M

79.38%

-24.07M

2023Q3

1835

205.61M

80.45%

-25.35M

2023Q2

2016

205.94M

80.75%

-21.55M

股東持股明細



名稱

持股數

佔比

持股變動

變動比例

公告日期

The Vanguard Group, Inc.

32.15M

12.37%

+2.54M

+8.57%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

28.28M

10.88%

-627.34K

-2.17%

Jun 30, 2025

MFS Investment Management

10.11M

3.89%

-469.39K

-4.44%

Jun 30, 2025

State Street Investment Management (US)

9.52M

3.66%

+540.48K

+6.02%

Jun 30, 2025

LSV Asset Management

7.99M

3.07%

+8.69K

+0.11%

Jun 30, 2025

Geode Capital Management, L.L.C.

4.40M

1.69%

-121.50K

-2.69%

Jun 30, 2025

Millennium Management LLC

9.09M

3.5%

+8.11M

+829.74%

Jun 30, 2025

AQR Capital Management, LLC

3.25M

1.25%

+1.88M

+136.10%

Jun 30, 2025

Gotham Asset Management, LLC

2.71M

1.04%

+1.31M

+93.22%

Jun 30, 2025

Dimensional Fund Advisors, L.P.

4.63M

1.78%

+459.24K

+11.02%

Jun 30, 2025

持股ETF



更新時間: 12月2日週二

機構名稱

佔比

State Street SPDR S&P Pharmaceuticals ETF

1.72%

Alger Russell Innovation ETF

1.39%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

1.22%

First Trust Health Care Alphadex Fund

1.1%

Invesco S&P SmallCap Health Care ETF

1.07%

Brandes US Small-Mid Cap Value ETF

1.05%

iShares U.S. Pharmaceuticals ETF

0.65%

Lattice Hartford Multifactor Small Cap ETF

0.5%

WisdomTree U.S. SmallCap Dividend Fund

0.5%

Royce Quant Small-Cap Quality Value ETF

0.45%

State Street SPDR S&P Pharmaceuticals ETF

佔比1.72%

Alger Russell Innovation ETF

佔比1.39%

Direxion Daily Pharmaceutical & Medical Bl 3X ETF

佔比1.22%

First Trust Health Care Alphadex Fund

佔比1.1%

Invesco S&P SmallCap Health Care ETF

佔比1.07%

Brandes US Small-Mid Cap Value ETF

佔比1.05%

iShares U.S. Pharmaceuticals ETF

佔比0.65%

Lattice Hartford Multifactor Small Cap ETF

佔比0.5%

WisdomTree U.S. SmallCap Dividend Fund

佔比0.5%

Royce Quant Small-Cap Quality Value ETF

佔比0.45%

分紅派息



近5年累計派現 1.03B 美元

公告日期

分紅計劃

股權登記日

現金發放日

除權除息日

Nov 10, 2025

OGN.NB Final Cash Dividend of gross USD 0.02 paid on Dec 11, 2025 going ex on Nov 20, 2025

Nov 20, 2025

Dec 11, 2025

Nov 20, 2025

Aug 05, 2025

OGN.NB Interim Cash Dividend of gross USD 0.02 paid on Sep 11, 2025 going ex on Aug 15, 2025

Aug 15, 2025

Sep 11, 2025

Aug 15, 2025

May 01, 2025

OGN.NB Interim Cash Dividend of gross USD 0.02 paid on Jun 12, 2025 going ex on May 12, 2025

May 12, 2025

Jun 12, 2025

May 12, 2025

Feb 13, 2025

OGN.NB Interim Cash Dividend of gross USD 0.28 paid on Mar 13, 2025 going ex on Feb 24, 2025

Feb 24, 2025

Mar 13, 2025

Feb 24, 2025

Oct 31, 2024

OGN.NB Final Cash Dividend of gross USD 0.28 paid on Dec 12, 2024 going ex on Nov 12, 2024

Nov 12, 2024

Dec 12, 2024

Nov 12, 2024

Aug 06, 2024

OGN.NB Interim Cash Dividend of gross USD 0.28 paid on Sep 12, 2024 going ex on Aug 16, 2024

Aug 16, 2024

Sep 12, 2024

Aug 16, 2024

May 02, 2024

OGN.NB Interim Cash Dividend of gross USD 0.28 paid on Jun 13, 2024 going ex on May 10, 2024

May 13, 2024

Jun 13, 2024

May 10, 2024

Feb 15, 2024

OGN.NB Interim Cash Dividend of gross USD 0.28 paid on Mar 14, 2024 going ex on Feb 23, 2024

Feb 26, 2024

Mar 14, 2024

Feb 23, 2024

Nov 02, 2023

OGN.NB Final Cash Dividend of gross USD 0.28 paid on Dec 14, 2023 going ex on Nov 10, 2023

Nov 13, 2023

Dec 14, 2023

Nov 10, 2023

Aug 08, 2023

OGN.NB Interim Cash Dividend of gross USD 0.28 paid on Sep 14, 2023 going ex on Aug 17, 2023

Aug 18, 2023

Sep 14, 2023

Aug 17, 2023

拆合股



公告日期

類型

比率

暫無數據

公告日期

類型

比率

暫無數據

常見問題

Organon & Co的前五大股東是誰？



Organon & Co的前五大股東如下：
The Vanguard Group, Inc.
持有股份：32.15M
佔總股份比例：12.37%。
BlackRock Institutional Trust Company, N.A.
持有股份：28.28M
佔總股份比例：10.88%。
MFS Investment Management
持有股份：10.11M
佔總股份比例：3.89%。
State Street Investment Management (US)
持有股份：9.52M
佔總股份比例：3.66%。
LSV Asset Management
持有股份：7.99M
佔總股份比例：3.07%。